These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36567327)

  • 21. Characterization of Psychotropic PRN Medications in a Canadian Psychiatric Intensive Care Unit.
    Casol M; Tong A; Ng JCY; McGloin R
    J Am Psychiatr Nurses Assoc; 2023; 29(2):103-111. PubMed ID: 34109871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of prn medication in a child and adolescent mental health inpatient service in France.
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Int J Psychiatry Clin Pract; 2009; 13(4):253-8. PubMed ID: 24916933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRN medication for psychiatric inpatients.
    Craven JL; Voore PM; Voineskos G
    Can J Psychiatry; 1987 Apr; 32(3):199-203. PubMed ID: 2882833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use and effectiveness of pro re nata psychotropic medications in children and adolescents: A systematic review.
    Asogwa K; Okudo J; Idowu J
    Indian J Psychiatry; 2017; 59(3):264-274. PubMed ID: 29085084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
    Takaesu Y; Watanabe K; Numata S; Iwata M; Kudo N; Oishi S; Takizawa T; Nemoto K; Yasuda Y; Tagata H; Tsuboi T; Tsujino N; Hashimoto N; Matsui Y; Hori H; Yamamori H; Sugiyama N; Suwa T; Kishimoto T; Hishimoto A; Usami M; Furihata R; Iwamoto K; Fujishiro H; Nakamura T; Mizuno K; Inagaki T; Katsumoto E; Tomita H; Ohi K; Muraoka H; Atake K; Iida H; Nagasawa T; Fujita J; Yamamura S; Onitsuka T; Murata A; Takayanagi Y; Noda H; Matsumura Y; Takezawa K; Iga JI; Ichihashi K; Ogasawara K; Yamada H; Inada K; Hashimoto R
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):642-648. PubMed ID: 31437336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.
    Yamada H; Motoyama M; Hasegawa N; Miura K; Matsumoto J; Ohi K; Yasui-Furukori N; Numata S; Takeshima M; Sugiyama N; Nagasawa T; Kubota C; Atake K; Tsuboi T; Ichihashi K; Hashimoto N; Inagaki T; Takaesu Y; Iga JI; Hori H; Onitsuka T; Komatsu H; Hishimoto A; Fukumoto K; Fujimoto M; Nakamura T; Nemoto K; Furihata R; Yamamura S; Yamagata H; Ogasawara K; Katsumoto E; Murata A; Iida H; Ochi S; Makinodan M; Kido M; Kishimoto T; Yasuda Y; Usami M; Suwa T; Inada K; Watanabe K; Hashimoto R
    BJPsych Open; 2022 Apr; 8(3):e83. PubMed ID: 35446248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey.
    Dong M; Zeng LN; Zhang Q; Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HFK; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK; Avasthi A; Grover S; Ng CH; Ungvari GS; Xiang YT
    Asian J Psychiatr; 2019 Oct; 45():74-80. PubMed ID: 31520884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings.
    Baker JA; Lovell K; Harris N
    J Clin Nurs; 2008 May; 17(9):1122-31. PubMed ID: 18416789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort.
    Prudent M; Dramé M; Jolly D; Trenque T; Parjoie R; Mahmoudi R; Lang PO; Somme D; Boyer F; Lanièce I; Gauvain JB; Blanchard F; Novella JL
    Drugs Aging; 2008; 25(11):933-46. PubMed ID: 18947261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient Safety and
    Vaismoradi M; Amaniyan S; Jordan S
    Pharmacy (Basel); 2018 Aug; 6(3):. PubMed ID: 30158511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotropic PRN use among older people's inpatient mental health services.
    Baker JA; Keady J; Hardman P; Kay J; Jones L; Jolley D
    J Psychiatr Ment Health Nurs; 2010 Jun; 17(5):463-8. PubMed ID: 20584243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic drug prescription in a psychiatric university hospital.
    Voirol P; Robert PA; Meister P; Oros L; Baumann P
    Pharmacopsychiatry; 1999 Jan; 32(1):29-37. PubMed ID: 10071180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prescription of psychotropic medications for patients discharged from a psychiatric emergency service.
    Ernst CL; Bird SA; Goldberg JF; Ghaemi SN
    J Clin Psychiatry; 2006 May; 67(5):720-6. PubMed ID: 16841621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19.
    Wang HJ; Kusumo RW; Kiss A; Tennen G; Marotta G; Viaje S; Lanctôt KL
    J Alzheimers Dis Rep; 2023; 7(1):575-587. PubMed ID: 37313488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro re nata medication for psychoses: the knowledge and beliefs of doctors and nurses.
    Geffen J; Cameron A; Sorensen L; Stokes J; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):642-8. PubMed ID: 12225448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nurses' attitudes towards the use of PRN psychotropic medications in acute and forensic mental health settings.
    Barr L; Wynaden D; Heslop K
    Int J Ment Health Nurs; 2018 Feb; 27(1):168-177. PubMed ID: 28337845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro re nata prescribing and administration for neuropsychiatric symptoms and pain in long-term care residents with dementia and memory problems: a cross-sectional study.
    Griffiths AW; Surr CA; Alldred DP; Baker J; Higham R; Spilsbury K; Thompson CA
    Int J Clin Pharm; 2019 Oct; 41(5):1314-1322. PubMed ID: 31342248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.